Back to SCHRODER INVESTMENT MANAGEMENT GROUP SCHRODER INVESTMENT MANAGEMENT GROUP

AUTLAUTL
27 quarters

Position history for SCHRODER INVESTMENT MANAGEMENT GROUPSCHRODER INVESTMENT MANAGEMENT GROUP's holdings in AUTOLUS THERAPEUTICS LTD

SCHRODER INVESTMENT MANAGEMENT GROUP holds 7.8M shares of AUTL (AUTOLUS THERAPEUTICS LTD), worth $12.9M as of 2026-Q2. The position was decreased (-17.4% shares). AUTL represents 0.0% of SCHRODER INVESTMENT MANAGEMENT GROUP's portfolio.

Current Value

$12.9M

Current Shares

7.8M

Total Value Change

-$14.7M

Total Shares Change

+5.7M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
7.8M
-17.4%
$12.9M0.0%$1.60
0
2026-Q1
Unchanged
9.5M
0.0%
$12.1M0.0%$1.62
0
2025-Q4
Increased
9.5M
+12.5%
$18.7M0.0%$1.97
32
2025-Q3
Increased
8.4M
+133.7%
$13.4M0.0%$1.59
45
2025-Q2
Unchanged
3.6M
0.0%
$8.2M0.0%$2.31
0
2025-Q1
Increased
3.6M
+26.0%
$6M0.0%$1.66
33
2024-Q4
Unchanged
2.9M
0.0%
$6.3M0.0%$2.21
0
2024-Q3
Increased
2.9M
+16.8%
$10.4M0.0%$3.63
32
2024-Q2
Increased
2.5M
+46.6%
$8.5M0.0%$3.48
38
2024-Q1
Unchanged
1.7M
0.0%
$10.7M0.0%$6.38
0
2023-Q4
Unchanged
1.7M
0.0%
$10.8M0.0%$6.44
0
2023-Q3
Unchanged
1.7M
0.0%
$3.9M0.0%$2.33
0
2023-Q2
Unchanged
1.7M
0.0%
$4M0.0%$2.28
0
2023-Q1
Unchanged
1.7M
0.0%
$3.1M0.0%$1.76
0
2022-Q4
Unchanged
1.7M
0.0%
$3.2M0.0%$1.90
0
2022-Q3
Unchanged
1.7M
0.0%
$3.6M0.0%$2.23
0
2022-Q2
Unchanged
1.7M
0.0%
$4.7M0.0%$2.83
0
2022-Q1
Unchanged
1.7M
0.0%
$7.1M0.0%$4.23
0
2021-Q4
Unchanged
1.7M
0.0%
$8.7M0.0%$5.29
0
2021-Q3
Unchanged
1.7M
0.0%
$11M0.0%$6.34
0
2021-Q2
Unchanged
1.7M
0.0%
$11.1M0.0%$6.54
0
2021-Q1
Decreased
1.7M
-50.0%
$9.6M0.0%$5.49
0
2020-Q4
Increased
3.3M
+113.7%
$29.9M0.0%$8.98
46
2020-Q3
Decreased
1.6M
-12.3%
$17.4M0.0%$12.00
0
2020-Q2
Decreased
1.8M
-14.8%
$28.6M0.1%$16.06
0
2020-Q1
Unchanged
2.1M
0.0%
$13.3M0.0%$5.63
0
2019-Q4
New
2.1M
-
$27.7M0.0%$14.09
40

Other major holders of AUTL: Blackstone Inc., WELLINGTON MANAGEMENT GROUP LLP, Avoro Capital Advisors LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used